Aw. Blume et al., Neurocognitive dysfunction in dually-diagnosed patients: A potential roadblock to motivating behavior change, J PSYCH DR, 31(2), 1999, pp. 111-115
Substance abuse has been associated with cognitive dysfunction, such as pro
blems with attention, reasoning, and memory. Certain psychiatric disorders
also have been associated with cognitive difficulties, thus placing dually-
diagnosed patients at high risk for cognitive impairment that could interfe
re with successful entry into or completion of therapy. Twenty-two dually-d
isordered inpatients' were administered the Brief Readiness to Change Quest
ionnaire to measure levels of motivation to change substance use, and a neu
ropsychological test battery that included the Wechsler Adult Intelligence
Scale-Revised (WAIS-R), the Halstead Category Test (HCT), and the Wechsler
Memory Scale-Revised (WMS-R). Higher general intellectual, executive, and m
emory functioning were significantly related to greater scores in readiness
to change substance abuse in this sample. Cognitive ability may be an impo
rtant variable to consider in the motivation and treatment of dually-diagno
sed patients.